These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29546402)

  • 1. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
    Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
    J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants.
    Bonnin FA; Talarico LB; Ferolla FM; Acosta PL; Phung E; Kumar A; Toledano A; Caratozzolo A; Neira P; Mascardi N; Satragno D; Contrini MM; Graham BS; Ruckwardt TJ; López EL;
    Vaccine; 2024 Nov; 42(25):126119. PubMed ID: 39003106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    Capella C; Chaiwatpongsakorn S; Gorrell E; Risch ZA; Ye F; Mertz SE; Johnson SM; Moore-Clingenpeel M; Ramilo O; Mejias A; Peeples ME
    J Infect Dis; 2017 Dec; 216(11):1398-1406. PubMed ID: 29029312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.
    Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA
    J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
    Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP;
    Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    Fuentes S; Hahn M; Chilcote K; Chemaly RF; Shah DP; Ye X; Avadhanula V; Piedra PA; Golding H; Khurana S
    J Infect Dis; 2020 Feb; 221(4):636-646. PubMed ID: 31745552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
    Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    Human S; Hotard AL; Rostad CA; Lee S; McCormick L; Larkin EK; Peret TCT; Jorba J; Lanzone J; Gebretsadik T; Williams JV; Bloodworth M; Stier M; Carroll K; Peebles RS; Anderson LJ; Hartert TV; Moore ML
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Henke DM; Patel KD; Piedra FA; Angelo LS; Shah DP; Chemaly RF; Piedra PA
    Viruses; 2021 May; 13(6):. PubMed ID: 34073490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.
    Patel SM; Jallow S; Boiditswe S; Madhi SA; Feemster KA; Steenhoff AP; Arscott-Mills T; Muthoga C; Ajibola G; Shapiro R; Shah SS; Cunningham CK; Kelly MS
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):349-356. PubMed ID: 31549157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
    Langley JM; Aggarwal N; Toma A; Halperin SA; McNeil SA; Fissette L; Dewé W; Leyssen M; Toussaint JF; Dieussaert I
    J Infect Dis; 2017 Jan; 215(1):24-33. PubMed ID: 27694633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
    Atwell JE; Thumar B; Formica MA; Robinson LJ; Walsh EE; King CL; Karron RA
    Pediatr Infect Dis J; 2019 Sep; 38(9):e199-e202. PubMed ID: 31408055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort.
    Sande CJ; Mutunga MN; Okiro EA; Medley GF; Cane PA; Nokes DJ
    J Med Virol; 2013 Nov; 85(11):2020-5. PubMed ID: 23983183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.
    Jounai N; Yoshioka M; Tozuka M; Inoue K; Oka T; Miyaji K; Ishida K; Kawai N; Ikematsu H; Kawakami C; Shimizu H; Mori M; Ishii KJ; Takeshita F
    EBioMedicine; 2017 Feb; 16():124-135. PubMed ID: 28111238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
    Mazur NI; Horsley NM; Englund JA; Nederend M; Magaret A; Kumar A; Jacobino SR; de Haan CAM; Khatry SK; LeClerq SC; Steinhoff MC; Tielsch JM; Katz J; Graham BS; Bont LJ; Leusen JHW; Chu HY
    J Infect Dis; 2019 Jan; 219(1):59-67. PubMed ID: 30107412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
    Jans J; Wicht O; Widjaja I; Ahout IM; de Groot R; Guichelaar T; Luytjes W; de Jonge MI; de Haan CA; Ferwerda G
    PLoS One; 2017; 12(1):e0170877. PubMed ID: 28135305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.